BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7880735)

  • 1. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):537-42. PubMed ID: 7880736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.
    Olive PL; Vikse CM; Banath JP
    Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
    Olive PL
    Acta Oncol; 1995; 34(3):301-5. PubMed ID: 7779413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide.
    Olive PL; Banáth JP; Sinnott LT
    Cancer Res; 2004 Aug; 64(15):5363-9. PubMed ID: 15289343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic fractions measured in murine tumors and normal tissues using the comet assay.
    Olive PL; Vikse CM; Durand RE
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):487-91. PubMed ID: 8005804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of subpopulations resistant to DNA-damaging agents in spheroids and murine tumours.
    Olive PL; Banáth JP; Durand RE
    Mutat Res; 1997 Apr; 375(2):157-65. PubMed ID: 9202726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
    Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
    Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicell spheroid response to drugs predicted with the comet assay.
    Olive PL; Banáth JP
    Cancer Res; 1997 Dec; 57(24):5528-33. PubMed ID: 9407963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice.
    Durand RE; Olive PL
    Radiat Oncol Investig; 1997; 5(5):213-9. PubMed ID: 9372543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine.
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 2001; 12(8):325-33. PubMed ID: 11589303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage from oxidants: influence of lesion complexity and chromatin organization.
    Olive PL; Johnston PJ
    Oncol Res; 1997; 9(6-7):287-94. PubMed ID: 9406234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.
    Lin PS; Ho KC; Yang SJ
    Cancer Lett; 1996 Aug; 105(2):249-55. PubMed ID: 8697451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia.
    Aquino-Parsons C; Luo C; Vikse CM; Olive PL
    Radiother Oncol; 1999 May; 51(2):179-85. PubMed ID: 10435811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.
    Olive PL; Horsman MR; Grau C; Overgaard J
    Br J Cancer; 1997; 76(6):694-9. PubMed ID: 9310232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of tirapazamine by multiple reductases in the nucleus.
    Delahoussaye YM; Evans JW; Brown JM
    Biochem Pharmacol; 2001 Nov; 62(9):1201-9. PubMed ID: 11705453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
    Zheng H; Olive PL
    Cancer Res; 1996 Jun; 56(12):2801-8. PubMed ID: 8665517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
    Siim BG; Menke DR; Dorie MJ; Brown JM
    Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing.
    Minchinton AI; Brown JM
    Br J Cancer; 1992 Dec; 66(6):1053-8. PubMed ID: 1457345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.